ArticleCommunications biology2024

Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia.

Tamara C A I Verbeek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.